Julie Kerr-Conte

8PUBLICATIONS
93CO-AUTHORS
PharmacogenomicsMedical molecular engineering of nucleic acids and proteinsCancer therapy (excl. chemotherapy and radiation therapy)AutoimmunityMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 25, 2026
Metabolic state determines the brain and direct islet effects of liraglutide on enhanced insulin secretion.

|Mar 25, 2026
NKX6.1 mRNA copy number is an actionable biomarker associated with islet function and clinical outcomes after islet transplantation.

Gianni Pasquetti, Julien Thévenet, Mikael Chetboun

|Oct 10, 2025
Functional recovery of islet β cells in human type 2 diabetes: Transcriptome signatures unveil therapeutic approaches.

Mara Suleiman, Toshiaki Sawatani, Marta Tesi

|Jun 12, 2024
Pharmaceutical targeting of the cannabinoid type 1 receptor impacts the crosstalk between immune cells and islets to reduce insulitis in humans.

Elise Wreven, María Soledad Ruiz de Adana, Stéphan Hardivillé

|Sep 17, 2021
Pushing the boundaries of organs before it's too late: pre-emptive regeneration.

Mehdi Maanaoui, Julie Kerr-Conte

|May 28, 2021
US food and drug administration (FDA) panel endorses islet cell treatment for type 1 diabetes: A pyrrhic victory?

Lorenzo Piemonti, Axel Andres, John Casey

Pageof 2

Frequent Collaborators

6 joint publications

François Pattou

4 joint publications

Caroline Bonner

4 joint publications

Julien Thévenet

4 joint publications

Valery Gmyr